Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Norberg PK"'
Autor:
Swartz AM; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Department of Pathology, Duke University Medical Center, Durham, NC, USA.; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Congdon KL; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Nair SK; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Department of Pathology, Duke University Medical Center, Durham, NC, USA.; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Li QJ; Department of Immunology, Duke University Medical Center, Durham, NC, USA., Herndon JE 2nd; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA., Suryadevara CM; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Riccione KA; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Archer GE; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Norberg PK; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Sanchez-Perez LA; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Sampson JH; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA. john.sampson@duke.edu.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA. john.sampson@duke.edu.; Department of Pathology, Duke University Medical Center, Durham, NC, USA. john.sampson@duke.edu.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2021 Jan 18; Vol. 6 (1), pp. 12. Date of Electronic Publication: 2021 Jan 18.
Autor:
Riccione KA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, USA., He LZ; Celldex Therapeutics, Hampton, NJ, USA., Fecci PE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA.; Department of Pathology, Duke University School of Medicine, Durham, NC, USA., Norberg PK; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA., Suryadevara CM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Department of Pathology, Duke University School of Medicine, Durham, NC, USA., Swartz A; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Department of Pathology, Duke University School of Medicine, Durham, NC, USA., Healy P; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA., Reap E; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA., Keler T; Celldex Therapeutics, Hampton, NJ, USA., Li QJ; Department of Immunology, Duke University School of Medicine, Durham, NC, USA., Congdon KL; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA., Sanchez-Perez L; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA., Sampson JH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC.; The Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA.; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, USA.; Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2018 Sep 05; Vol. 7 (12), pp. e1502904. Date of Electronic Publication: 2018 Sep 05 (Print Publication: 2018).
Autor:
Reap EA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Suryadevara CM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Batich KA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Sanchez-Perez L; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Archer GE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Schmittling RJ; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Norberg PK; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Herndon JE 2nd; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina., Healy P; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina., Congdon KL; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Gedeon PC; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Campbell OC; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Swartz AM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Riccione KA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Yi JS; Division of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, North Carolina., Hossain-Ibrahim MK; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Saraswathula A; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Nair SK; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina.; Division of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, North Carolina., Dunn-Pirio AM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Broome TM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Weinhold KJ; Division of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, North Carolina., Desjardins A; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Neurology, Duke University Medical Center, Durham, North Carolina., Vlahovic G; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., McLendon RE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Friedman AH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Friedman HS; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Bigner DD; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Fecci PE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Mitchell DA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina. john.sampson@duke.edu duane.mitchell@neurosurgery.ufl.edu.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Sampson JH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina. john.sampson@duke.edu duane.mitchell@neurosurgery.ufl.edu.; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Publikováno v:
Cancer research [Cancer Res] 2018 Jan 01; Vol. 78 (1), pp. 256-264. Date of Electronic Publication: 2017 Nov 01.
Autor:
Wu Y; Department of Biomedical Engineering, Duke University, Durham, North Carolina, 27708, United States., Norberg PK; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina 27710, United States., Reap EA; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina 27710, United States., Congdon KL; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina 27710, United States., Fries CN; Department of Biomedical Engineering, Duke University, Durham, North Carolina, 27708, United States., Kelly SH; Department of Biomedical Engineering, Duke University, Durham, North Carolina, 27708, United States., Sampson JH; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina 27710, United States., Conticello VP; Department of Chemistry, Emory University, Atlanta, Georgia, 30322, United States., Collier JH; Department of Biomedical Engineering, Duke University, Durham, North Carolina, 27708, United States.
Publikováno v:
ACS biomaterials science & engineering [ACS Biomater Sci Eng] 2017 Dec 11; Vol. 3 (12), pp. 3128-3132. Date of Electronic Publication: 2017 Sep 11.
Autor:
Saraswathula A; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA., Reap EA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Box 3050, Durham, NC, 27710, USA., Choi BD; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Box 3050, Durham, NC, 27710, USA.; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Schmittling RJ; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Box 3050, Durham, NC, 27710, USA., Norberg PK; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Box 3050, Durham, NC, 27710, USA., Sayour EJ; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Box 3050, Durham, NC, 27710, USA.; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Herndon JE 2nd; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA., Healy P; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA., Congdon KL; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Box 3050, Durham, NC, 27710, USA., Archer GE; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Box 3050, Durham, NC, 27710, USA., Sanchez-Perez L; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Box 3050, Durham, NC, 27710, USA., Sampson JH; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA. john.sampson@duke.edu.; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Box 3050, Durham, NC, 27710, USA. john.sampson@duke.edu.; Division of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, NC, USA. john.sampson@duke.edu.; Department of Pathology, Duke University Medical Center, Durham, NC, USA. john.sampson@duke.edu.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2016 Feb; Vol. 65 (2), pp. 205-11. Date of Electronic Publication: 2016 Jan 12.
Autor:
Sampson JH; Authors' Affiliations: Duke Brain Tumor Immunotherapy Program, Division of Neurosurgery, Department of Surgery; Department of Pathology; The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina; and Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Choi BD, Sanchez-Perez L, Suryadevara CM, Snyder DJ, Flores CT, Schmittling RJ, Nair SK, Reap EA, Norberg PK, Herndon JE 2nd, Kuan CT, Morgan RA, Rosenberg SA, Johnson LA
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2014 Feb 15; Vol. 20 (4), pp. 972-84. Date of Electronic Publication: 2013 Dec 18.
Autor:
Reap EA; AlphaVax, Inc., 2 Triangle Drive, P.O. Box 110307, Research Triangle Park, NC 27709-0307, USA. reap@alphavax.com, Dryga SA, Morris J, Rivers B, Norberg PK, Olmsted RA, Chulay JD
Publikováno v:
Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2007 Jun; Vol. 14 (6), pp. 748-55. Date of Electronic Publication: 2007 Apr 18.